Trump Brokers Major Drug Price Cuts in the U.S.; What It Means for India
Washington, D.C.: In a landmark move, U.S. President Donald Trump has struck a deal with nine major pharmaceutical companies to significantly lower drug prices in the country. Trump emphasized that for decades, Americans have been forced to pay some of the highest prices for medications globally. Under the agreement, several key drugs will see substantial price reductions.
Impact on Global Pharma and IndiaThis announcement is expected to have far-reaching effects on the global pharmaceutical market, including India’s generic drug exports. The U.S. is now moving toward an international reference pricing system to determine drug costs. The nine pharmaceutical giants—Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche's Genentech, Boehringer Ingelheim, and Novartis—have agreed t...









